JP2005519863A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519863A5
JP2005519863A5 JP2003524598A JP2003524598A JP2005519863A5 JP 2005519863 A5 JP2005519863 A5 JP 2005519863A5 JP 2003524598 A JP2003524598 A JP 2003524598A JP 2003524598 A JP2003524598 A JP 2003524598A JP 2005519863 A5 JP2005519863 A5 JP 2005519863A5
Authority
JP
Japan
Prior art keywords
wetting agents
product
side reactions
reagents
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519863A (ja
Filing date
Publication date
Priority claimed from CZ20013153A external-priority patent/CZ292832B6/cs
Application filed filed Critical
Publication of JP2005519863A publication Critical patent/JP2005519863A/ja
Publication of JP2005519863A5 publication Critical patent/JP2005519863A5/ja
Pending legal-status Critical Current

Links

JP2003524598A 2001-08-30 2002-08-30 溶解性に優れたフラバノリグナン調製物 Pending JP2005519863A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20013153A CZ292832B6 (cs) 2001-08-30 2001-08-30 Způsob přípravy silymarinu se zvýšenou rozpustností
PCT/US2002/027713 WO2003020291A1 (en) 2001-08-30 2002-08-30 Increased solubility flavanolignan preparations

Publications (2)

Publication Number Publication Date
JP2005519863A JP2005519863A (ja) 2005-07-07
JP2005519863A5 true JP2005519863A5 (enExample) 2009-09-10

Family

ID=5473538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524598A Pending JP2005519863A (ja) 2001-08-30 2002-08-30 溶解性に優れたフラバノリグナン調製物

Country Status (15)

Country Link
US (1) US7384919B2 (enExample)
EP (1) EP1420802B1 (enExample)
JP (1) JP2005519863A (enExample)
KR (1) KR20040074052A (enExample)
CN (1) CN1582159A (enExample)
AT (1) ATE381340T1 (enExample)
AU (1) AU2002323517B2 (enExample)
CA (1) CA2458963A1 (enExample)
CZ (1) CZ292832B6 (enExample)
DE (1) DE60224202T2 (enExample)
MX (1) MXPA04001700A (enExample)
NO (1) NO20041300L (enExample)
NZ (1) NZ531429A (enExample)
TW (1) TWI238065B (enExample)
WO (1) WO2003020291A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
CN101969766B (zh) * 2007-10-17 2015-05-06 托德·F·奥沃凯泰斯 固态化合物的改良方法及使用其制备的共-无定形组合物
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
CZ2008407A3 (cs) 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
JP5841048B2 (ja) * 2009-05-14 2016-01-06 エウロメッド・エセ・ア ウイルス性肝炎の治療のための非晶質シリビニン
US20120083013A1 (en) * 2009-05-19 2012-04-05 Suntory Holdings Limited Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
CN102228430B (zh) * 2011-06-14 2015-12-09 中国中医科学院中药研究所 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
WO2015187974A1 (en) 2014-06-06 2015-12-10 Ovokaitys Todd Frank Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
JP6348024B2 (ja) * 2014-09-03 2018-06-27 株式会社ファンケル 水分散性の良いシリマリン含有組成物
KR101598752B1 (ko) * 2015-01-28 2016-02-29 순천향대학교 산학협력단 표면적 및/또는 다공성이 조절된 당알콜을 담체로 이용한 리포솜 조성물 및 그의 제조방법
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR20230129426A (ko) 2020-12-08 2023-09-08 토드 프랭크 오보케이티스 줄기 세포 생산 증가를 위한 방법 및 시스템

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554662A (en) * 1976-05-05 1979-10-24 Inverni Della Beffa Spa Polyhydroxyphenylchromanones
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
US4767508A (en) * 1986-02-27 1988-08-30 Nippon Mining Co., Ltd. Strike plating solution useful in applying primer plating to electronic parts
IT1222012B (it) 1987-07-10 1990-08-31 Indena Spa Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
US5196448A (en) 1991-01-22 1993-03-23 Stiefel Laboratories, Inc. Antiinflammatory compositions and method of use
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CZ287657B6 (cs) 1996-06-12 2001-01-17 Mikrobiologický Ústav Av Čr Glykosidy silybininu a způsob jejich výroby
DE19744459A1 (de) 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen

Similar Documents

Publication Publication Date Title
JP2005519863A5 (enExample)
JP2003524592A5 (enExample)
JP2006509054A5 (enExample)
DE60306760D1 (de) Selbstreinigende sprühdüse
JP2002523475A5 (enExample)
JP2004529167A5 (enExample)
WO2004000234A3 (en) Breath freshening and oral cleansing product with cinnamaldehyde
WO2001066564A3 (en) Gamma-secretase inhibitors
CA2341031A1 (en) Novel salt form of pantoprazole
ATE237587T1 (de) 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
WO2003053333A3 (en) Concentrated frormulations and methods for neutralizing chemical and biological toxants
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
RU97118735A (ru) Модельная композиция для выплавляемых моделей
JP2005516946A5 (enExample)
JP2006505596A5 (enExample)
JP2008512527A5 (enExample)
KR20040058325A (ko) 소취제 및 이를 함유하는 세발 화장료
Hür et al. The acidities of some indoles
CA2361532A1 (en) Light, extruded compositions containing a light, extrudable, ceramic carrier, methods for their use, and processes for their preparation
HU0102987D0 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
JP2005535635A5 (enExample)
JPH09169701A5 (enExample)
RU2002121504A (ru) Лекарственные средства для лечения дегенеративного артрита
JPH10251697A5 (enExample)
JP2000247880A5 (enExample)